Skip to main content
. Author manuscript; available in PMC: 2020 Aug 24.
Published in final edited form as: Clin Cancer Res. 2019 May 3;25(15):4663–4673. doi: 10.1158/1078-0432.CCR-18-4142

Figure 5. Association of PD-1, LAG-3 and TIM-3 with survival in retrospective cohorts.

Figure 5.

(A-F) Association of markers with 5-year overall survival in 379 NSCLC cases from cohort # 1 (A-C) and 252 cases from the cohort # 2 (D-F). Elevated expression of the markers was defined as signal above the 85th percentile of the cohort.